These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8871773)

  • 21. The Tridimensional Personality Questionnaire: changes during psychological treatment of social phobia.
    Hofmann SG; Loh R
    J Psychiatr Res; 2006 Apr; 40(3):214-20. PubMed ID: 15935382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the five-factory inventory in characterizing patients with major depressive disorder.
    Petersen T; Bottonari K; Alpert JE; Fava M; Nierenberg AA
    Compr Psychiatry; 2001; 42(6):488-93. PubMed ID: 11704941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding.
    Coccaro EF; Kavoussi RJ; Sheline YI; Berman ME; Csernansky JG
    Neuropsychopharmacology; 1997 Mar; 16(3):211-6. PubMed ID: 9138437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severity of somatization and its relationship to psychiatric disorders and personality.
    Russo J; Katon W; Sullivan M; Clark M; Buchwald D
    Psychosomatics; 1994; 35(6):546-56. PubMed ID: 7809357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet serotonergic functions and light therapy in seasonal affective disorder.
    Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
    Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet serotonin-2 receptor binding sites in depression and suicide.
    Pandey GN; Pandey SC; Janicak PG; Marks RC; Davis JM
    Biol Psychiatry; 1990 Aug; 28(3):215-22. PubMed ID: 2378926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet serotonin-2 receptors in obsessive-compulsive disorder.
    Pandey SC; Kim SW; Davis JM; Pandey GN
    Biol Psychiatry; 1993 Mar; 33(5):367-72. PubMed ID: 8471695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Italian validation of Multiple Visual Analogue Scales for Bipolarity (MVAS-BP) of Ahearn and Carroll].
    Staccini L; Tomba E; Ottolini F; Ruini C; Fava GA
    Riv Psichiatr; 2012; 47(1):50-8. PubMed ID: 22358217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet binding characteristics distinguish placebo responders from nonresponders in depression.
    Sheline YI; Black KJ; Bardgett ME; Csernansky JG
    Neuropsychopharmacology; 1995 Jul; 12(4):315-22. PubMed ID: 7576008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects.
    Marseille R; Lee R; Coccaro EF
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):277-81. PubMed ID: 22019855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Tridimensional Personality Questionnaire in depression: state versus trait issues.
    Chien AJ; Dunner DL
    J Psychiatr Res; 1996; 30(1):21-7. PubMed ID: 8736463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment.
    Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN
    Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression.
    Nelson EC; Cloninger CR
    J Affect Disord; 1995 Oct; 35(1-2):51-7. PubMed ID: 8557887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Tridimensional Personality Questionnaire: Structural Validity and Comparison with the Multidimensional Personality Questionnaire.
    Waller NG; Lilienfeld SO; Tellegen A; Lykken DT
    Multivariate Behav Res; 1991 Jan; 26(1):1-23. PubMed ID: 26782609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder.
    Pfohl B; Black D; Noyes R; Kelley M; Blum N
    Biol Psychiatry; 1990 Jul; 28(1):41-6. PubMed ID: 2165423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
    Ruegg RG; Gilmore J; Ekstrom RD; Corrigan M; Knight B; Tancer M; Leatherman ME; Carson SW; Golden RN
    Biol Psychiatry; 1997 Dec; 42(12):1123-9. PubMed ID: 9426882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
    Smedh K; Spigset O; Allard P; Mjörndal T; Adolfsson R
    Biol Psychiatry; 1999 Feb; 45(4):464-70. PubMed ID: 10071719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tridimensional personality questionnaire (TPQ) and depression.
    Hansenne M; Pitchot W; Gonzalez Moreno A; Machurot PY; Ansseau M
    Eur Psychiatry; 1998; 13(2):101-3. PubMed ID: 19698607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.